John B. Bode, Director at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 10,000 shares at $5.13 ($51K) on 2023-09-05, disclosed to the SEC on 2023-09-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZVRA | BUY | 2024-07-15 | $59K | — | Filing → |
| ZVRA | BUY | 2023-05-19 | $50K | — | Filing → |
| TPUB | BUY | 2014-11-12 | $51K | — | Filing → |